Please login to the form below

Not currently logged in

The Porterhouse Medical Group Award for Excellence in Professional Education Programmes

Sponsored by

Back to results


PEAK – Progressing Evidence in Aktinic Keratosis to Optimise Care for Patients

by Leading Edge for Leo Pharma

Summary of work

Actinic keratosis (AK) lesions are rough patches of skin caused by years of sun exposure. Although most lesions are not serious and may spontaneously resolve, some will progress to sun-related skin cancer (squamous cell carcinoma; SCC). AK lesions are surrounded by areas of subclinical, non-visible sun damage that can develop into visible AK lesions and SCC (called field cancerisation), which is treated by field therapy; however, routine practice has been that physicians only treat the lesion, not the entire field.

The Progressing Evidence in AK (PEAK) programme is an EU-wide initiative led by globally-renowned experts to drive a belief-shift in the importance of treating the field in AK.

A Steering Committee of eight experts was responsible for identifying barriers to effective AK management, developing a treatment algorithm, the AK Field Assessment Scale (AK-FAS), and an educational roll-out programme to engage the dermatology community. The Steering Committee was pivotal to the roll-out of the programme, delivering symposia at the EADV and EADO congresses and authoring publication of the AK-FAS in Acta Dermato Venereologica. Implementation of the AK-FAS has already led to a more standardised approach to diagnosing and treating AK.

Judges' comments

Leading Edge and Leo Pharma have put together a strong, systematic and well thought through programme. It had good stakeholder feedback and the judges look forward to seeing how it develops.


Haemophilia Academy - by AXON Communications for Core sponsorship for the Haemophilia Academy is provided as an unrestricted educational grant from Novo Nordisk Health Care AG. Additional sponsorship provided as an unrestricted educational grant from Instrumentation Laboratory

Addressing the Unmet Need in Hyperkalaemia - by Firstlight Public Relations for Vifor Pharma UK

PEAK – Progressing Evidence in Aktinic Keratosis to Optimise Care for Patients - by Leading Edge for Leo Pharma

Category Sponsors

Louise Dunn, Communications Consultant – Co-chair Communiqué Awards

Key dates

Entry deadline 11 March 2021
Extended entry deadline 18 March 2021
(additional fee applies)
Judging days May 2021
Awards Ceremony 1st September 2021

Contact information:

For sponsorship opportunities:
Sales Team
Tel: +44 (0)1372 414200

General event enquiries:
Debbie Tuesley
Tel: +44 (0)1372 414243